Qube Research & Technologies Ltd

Position in NVO — Novo Nordisk A S

CIK 1729829 LONDON, X0

Back to NVO Full portfolio

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$24,941,599

+$24,941,599 QoQ

Shares Held

520,267

Ownership

0.012%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#84

of 1,348 holders

Holding Since

Jun 2020

21 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Derivatives in NVO

reported options exposure · as of Jun 30, 2026

CallValue

$31,506,168

CallShares

657,200

PutValue

$19,938,246

PutShares

415,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $1,498,530,307 across 11 Drug Manufacturers - General names. NVO ranks #9 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	346,498	$415,600,130
2	GILD	Gilead Sciences, Inc.	3,086,166	$389,906,212
3	JNJ	Johnson & Johnson	752,337	$191,071,027
4	BMY	Bristol Myers Squibb Co	3,093,958	$178,273,859
5	MRK	Merck & Co., Inc.	1,044,210	$134,180,985
6	AZN	Astrazeneca PLC	375,473	$71,197,190
7	GSK	GSK plc	1,078,767	$56,548,966
8	SNY	Sanofi	634,794	$27,080,312

All Filings in NVO

Export CSV

38 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$19,938,246	415,900	-7.1%	Put	Sole	2026-08-14
2026-06-30	$31,506,168	657,200	-26.0%	Call	Sole	2026-08-14
2026-06-30	$24,941,599	520,267	+203.5%	Shares	Sole	2026-08-14
2026-03-31	$32,652,375	888,500	-46.7%	Call	Sole	2026-05-15
2026-03-31	$16,445,625	447,500	-34.3%	Put	Sole	2026-05-15
2025-12-31	$8,721,646	171,416	-80.6%	Shares	Sole	2026-02-17
2025-12-31	$84,771,168	1,666,100	+38.8%	Call	Sole	2026-02-17
2025-12-31	$34,634,016	680,700	+35.9%	Put	Sole	2026-02-17
2025-09-30	$27,783,843	500,700	+29.3%	Put	Sole	2025-11-14
2025-09-30	$66,615,745	1,200,500	+36.4%	Call	Sole	2025-11-14
2025-06-30	$26,724,544	387,200	+51.5%	Put	Sole	2025-08-14
2025-06-30	$60,765,208	880,400	+93.6%	Call	Sole	2025-08-14
2025-03-31	$61,324,200	883,125	+3.3%	Shares	Sole	2025-05-15
2025-03-31	$17,748,864	255,600	+61.9%	Put	Sole	2025-05-15
2025-03-31	$31,581,312	454,800	+73.4%	Call	Sole	2025-05-15
2024-12-31	$73,559,314	855,142	+29.1%	Shares	Sole	2025-02-14
2024-12-31	$22,563,046	262,300	+63.7%	Call	Sole	2025-02-14
2024-12-31	$13,582,558	157,900	-7.1%	Put	Sole	2025-02-14
2024-09-30	$19,075,014	160,200	+308.7%	Call	Sole	2024-11-14
2024-09-30	$78,853,274	662,243	-8.9%	Shares	Sole	2024-11-14
2024-09-30	$20,229,993	169,900	+571.5%	Put	Sole	2024-11-14
2024-06-30	$3,611,322	25,300	+7.7%	Put	Sole	2024-08-14
2024-06-30	$103,720,878	726,642	+0.9%	Shares	Sole	2024-08-14
2024-06-30	$5,595,408	39,200	+125.3%	Call	Sole	2024-08-14
2024-03-31	$92,464,820	720,131	+101.3%	Shares	Sole	2024-05-14
2023-12-31	$2,431,075	23,500	—	Put	Sole	2024-02-13
2023-12-31	$37,011,305	357,770	-39.8%	Shares	Sole	2024-02-13
2023-12-31	$1,800,030	17,400	—	Call	Sole	2024-02-13
2023-09-30	$54,047,824	594,324	+288.4%	Shares	Sole	2023-11-13
2023-06-30	$24,765,815	153,036	+206.9%	Shares	Sole	2023-08-14
2022-09-30	$4,967,352	49,858	-53.7%	Shares	Sole	2022-11-14
2022-06-30	$12,007,251	107,756	+4119.1%	Shares	Sole	2022-08-15
2021-12-31	$286,048	2,554	-95.8%	Shares	Sole	2022-02-10
2021-09-30	$5,902,214	61,475	+69.1%	Shares	Sole	2021-11-12
2021-03-31	$2,451,323	36,359	-27.3%	Shares	Sole	2021-05-14
2020-12-31	$3,491,591	49,987	-22.8%	Shares	Sole	2021-02-16
2020-09-30	$4,495,037	64,742	-26.4%	Shares	Sole	2020-11-12
2020-06-30	$5,757,132	87,922	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.